Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China flag China · Delayed Price · Currency is CNY
19.68
+0.09 (0.46%)
Nov 17, 2026, 3:00 PM CST

SHA:600332 Revenue

Guangzhou Baiyunshan Pharmaceutical Holdings Company had revenue of 19.99B CNY in the quarter ending September 30, 2026, with 1.08% growth. This brings the company's total for the last twelve months to 78.13B, up 0.76% year-over-year. In the year 2025, Guangzhou Baiyunshan Pharmaceutical Holdings Company had annual revenue of 77.66B with 3.55% growth. That makes Guangzhou Baiyunshan Pharmaceutical Holdings Company the 1,291st largest company in the world by revenue and 118th in China.

Revenue (ttm)
78.13B
Revenue Growth
+0.76%
P/S Ratio
0.38
Revenue / Employee
2.89M
Employees
26,365
Market Cap
30.03B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Pharmaceutical Commercial 58.17B 67.9%
  • Natural Beverage 9.73B 11.4%
  • Modern Chinese Medicine 7.52B 8.8%
  • Others 6.48B 7.6%
  • Chemical Pharmaceutical Technology 3.77B 4.4%

By Geography

Chart
  • China 77.36B 99.6%
  • Other Countries/Regions 294.31M 0.4%
Fiscal year ended Dec 31, 2025 See the full SHA:600332 breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202577.66B2.66B3.55%
Dec 31, 202474.99B-522.58M-0.69%
Dec 31, 202375.52B4.73B6.68%
Dec 31, 202270.79B1.77B2.57%
Dec 31, 202169.01B7.34B11.90%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Jan 1, 2018 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.